Nimbus Therapeutics' Series A - II Round

Nimbus Therapeutics raised a round of funding on June 27, 2013. Investors include Monsanto Growth Ventures.

Nimbus Therapeutics, formerly Nimbus Discovery, harnesses the power of computational chemistry to design breakthroughs for the treatment of substantial and underserved human diseases. The company's fo…

Articles about Nimbus Therapeutics' Series A - II Round: